Antipsychotics from theory to practice:
integrating clinical and basic
data
by
Tandon R, Milner K, Jibson MD
University of Michigan Medical Center,
Ann Arbor 48109-0120, USA.
rtandon@umich.edu
J Clin Psychiatry 1999; 60 Suppl 8:21-8
ABSTRACT
The recent introduction of the atypical antipsychotics into the treatment
arena for psychoses and related disorders comes with justifiable excitement.
These newer antipsychotics offer several clinical benefits over the conventional
antipsychotics, which have been the mainstays of care thus far. The primary
advantage of these atypical agents is their superior side effect profiles,
particularly with regard to extrapyramidal side effects (EPS). The implications
from a reduction in EPS touch on virtually every aspect of pathology in
schizophrenic illness, including short- and long-term movement disorders,
negative symptoms, noncompliance, cognitive dysfunction, and dysphoria. It
should be emphasized that while atypical antipsychotics share many clinical
attributes, there are also substantial differences among them. This review will
examine the pharmacology, clinical efficacy, and side effect profiles of the
atypical antipsychotics and attempt to relate the attributes observed in
clinical practice and clinical trials to their basic pharmacologic profiles.
There is a fair, but not perfect, correspondence between the pharmacologic
profiles of the different atypical antipsychotics and their respective clinical
attributes. After a comparative overview of their receptor-binding profiles, a
brief pharmacokinetic summary will be provided. Finally, the clinical profiles
of these agents will be summarized with regard to both their efficacy and
adverse effects.
Zotepine
Clozapine
Quetiapine
LY2140023
Olanzapine
Risperidone
Trimipramine
Antipsychotics
Chlorpromazine
The deficit syndrome
Antipsychotics: review
Schizoaffective disorder
Bipolars and schizophrenics
Anhedonia and schizophrenia
Atypical antipsychotic agents
Partial dopamine agonists for psychosis
Big Pharma and drugs for schizophrenics
Atypical antipsychotics for schizophrenia
Diminished pain sensitivity in schizophrenia
Prescribing anti-psychotics to control children
Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family